Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia B Landersdorfer

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Clinical Pharmacokinetics|May 6, 2015
Population Pharmacokinetic/Pharmacodynamic Modelling of Dipeptidyl Peptidase IV InhibitorsCornelia B Landersdorfer
International Journal of Antimicrobial Agents|May 31, 2021
Antibiotic pharmacokinetic/pharmacodynamic modelling: MIC, pharmacodynamic indices and beyondGauri G Rao, Cornelia B Landersdorfer
Clinical Pharmacology and Therapeutics|February 11, 2021
Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic ShockCornelia B Landersdorfer, Roger L Nation
Frontiers in Pharmacology|November 15, 2021
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move ForwardCornelia B Landersdorfer, Roger L Nation
Pediatric Pulmonology|July 10, 2019
Optimization of dosing regimens of intravenous colistin in patients with cystic fibrosis: What data are required?Roger L Nation, Cornelia B Landersdorfer
The AAPS Journal|March 5, 2011
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic modelsJurgen B Bulitta, Cornelia B Landersdorfer
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
Colistin: how should it be dosed for the critically ill?Cornelia B Landersdorfer, Roger L Nation
Drug Metabolism and Pharmacokinetics|October 7, 2010
Pharmacokinetic/pharmacodynamic modeling of glucose clamp effects of inhaled and subcutaneous insulin in healthy volunteers and diabetic patientsCornelia B Landersdorfer, William J Jusko
Clinical Pharmacokinetics|June 20, 2008
Pharmacokinetic/pharmacodynamic modelling in diabetes mellitusCornelia B Landersdorfer, William J Jusko
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2026
From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform PK/PD targets for teicoplaninCornelia B Landersdorfer, Kelly A Cairns
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Clinical Pharmacokinetics|May 6, 2015
Population Pharmacokinetic/Pharmacodynamic Modelling of Dipeptidyl Peptidase IV InhibitorsCornelia B Landersdorfer
International Journal of Antimicrobial Agents|May 31, 2021
Antibiotic pharmacokinetic/pharmacodynamic modelling: MIC, pharmacodynamic indices and beyondGauri G Rao, Cornelia B Landersdorfer
Clinical Pharmacology and Therapeutics|February 11, 2021
Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic ShockCornelia B Landersdorfer, Roger L Nation
Frontiers in Pharmacology|November 15, 2021
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move ForwardCornelia B Landersdorfer, Roger L Nation
Pediatric Pulmonology|July 10, 2019
Optimization of dosing regimens of intravenous colistin in patients with cystic fibrosis: What data are required?Roger L Nation, Cornelia B Landersdorfer
The AAPS Journal|March 5, 2011
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic modelsJurgen B Bulitta, Cornelia B Landersdorfer
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
Colistin: how should it be dosed for the critically ill?Cornelia B Landersdorfer, Roger L Nation
Drug Metabolism and Pharmacokinetics|October 7, 2010
Pharmacokinetic/pharmacodynamic modeling of glucose clamp effects of inhaled and subcutaneous insulin in healthy volunteers and diabetic patientsCornelia B Landersdorfer, William J Jusko
Clinical Pharmacokinetics|June 20, 2008
Pharmacokinetic/pharmacodynamic modelling in diabetes mellitusCornelia B Landersdorfer, William J Jusko
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2026
From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform PK/PD targets for teicoplaninCornelia B Landersdorfer, Kelly A Cairns
Pageof 14